The Filing Desk

HeartFlow vs SOPHiA GENETICS

HeartFlow HTFL · SOPHiA GENETICS SOPH · Health Care Technology

HeartFlow reported revenue of $176 million in fiscal 2025, 2.3 times SOPHiA GENETICS's $77 million in fiscal 2025. HeartFlow's revenue grew 39.9% in its latest year, and SOPHiA GENETICS's grew 18.6%. HeartFlow had an operating margin of -36.4%, against -91.8% at SOPHiA GENETICS. Free cash flow was −$59 million at HeartFlow and −$36 million at SOPHiA GENETICS.

Side by side

HeartFlowSOPHiA GENETICS
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$176M$77M
Revenue growth39.9%18.6%
Revenue growth a year, last 5 years—22.2%
Gross margin76.8%67.4%
Operating margin−36.4%−91.8%
Net margin−66.3%−102.2%
Free cash flow−$59M−$36M
Free cash flow margin−33.5%−47.2%
Return on capital—−207.1%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count587.1%2.2%
Last close$44.63$6.68
P/E at the last close——
Insider trades, last 12 monthsbought $1.1 million, sold $142.3 millionbought $99,000, sold $4.2 million
Piotroski F-score—2 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
HeartFlowSOPHiA GENETICS
Operating margin
Percent of revenue
HeartFlowSOPHiA GENETICS
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
HeartFlowSOPHiA GENETICS

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the HeartFlow and SOPHiA GENETICS pages.